(fibroids) were investigated using data from the Oxford Family Planning Association study, a long term follow up study of women using various methods of contraception. For each of 535 women who had had a fibroid an individual control was selected who matched the patient on age, date ofentry into the cohort, and family planning clinic at recruitment and'who was alive (and still being followed up) at the date the patient underwent surgery for fibroids. Case-control analysis showed that reproductive experiences were closely linked to development of fibroids. Risk offibroids decreased consistently with increasing number ofterm pregnancies; women with five term pregnancies had only a quarter of the risk of women who had had none. Risk also decreased consistently with increasing duration of oral contraceptive use; the risk of fibroids was reduced by some 31% in women who had used oral contraceptives for 10 years.
Risk was strongly related to weight: women who weighed under 55 kg had a particularly low risk, and overall the risk rose roughly 21% for each 10 kg increase. Cigarette smoking was associated with a decreased risk of fibroids; smokers of 20 cigarettes a day had a risk roughly two thirds that of non-smokers.
These risk factors have all previously been identified as risk factors for endometrial cancer; this'strongly suggests that the underlying risk factor is "unopposed" oestrogen.
Introduction
Uterine leiomyomas are the most common pelvic neoplasms and may be the most common of all tumours in women' 2; they are benign tumours of smooth muscle, commonly referred to as fibroids. Despite the importance of these tumours, little is known about their epidemiology or aetiology. Fibroids are most commonly diagnosed during reproductive life, usually in the fourth to fifth decade,3 and they tend to shrink or fibrose after the menopause.2 Fibroids have been consistently associated with infertility: in one review of several large series totalling 1698 patients, 464 (27%) had a history of infertility.4 Case reports have suggested that oral contraceptives may play a part in the development or growth of the tumours,5 but a study of the records relating to a small series of women who had undergone hysterectomy, with and without fibroids, suggested that an inverse relation may in fact exist.6 Although it is generally thought that fibroids rapidly increase in size during pregnancy,2 detailed studies have failed to confirm this. 7 Although not well documented, it is widely accepted that fibroids are much more common in American black women than American white women2: one suggested explanation for this is that black women have a higher prevalence of pelvic infections than white women and that such infections cause myometrial irritation leading to abnormal uterine growth.8 This hypothesis is untested, and we could find no useful data on this issue.
Using data from the Oxford Family Planning Association cohort study, we have tested some of these hypotheses and provide other relevant information.
Methods
The Results Table I shows the incidence for surgically (pathologically) confirmed fibroids by age at surgery. There was a steady increase in incidence with increasing age up to the age group 45-49; the condition was uncommon under 30 and was roughly three times commoner in women in their 40s than Of the women with fibroids, 283 (53%) had used oral contraceptives at some time compared with 315 (59%) of the controls, and there was a steady decrease in risk with increasing duration of oral contraceptive use (data not shown). Oral contraceptive use within the six months before pathological diagnosis of fibroids was particularly associated with a decreased risk, but there was little further change in risk as the time between last use of oral contraceptives and diagnosis increased (table III) . This strongly suggested, and the detailed information we had on a proportion of patients confirmed, that in many cases the use of oral contraceptives had been abandoned between the initial clinical diagnosis of fibroids and the final pathological diagnosis. Accordingly, for the purposes of understanding aetiology, we restricted attention to oral contraceptive use up to six months before pathological diagnosis (table III) . The risk clearly fell with increasing duration of use of oral contraceptives. Table V shows the relation between fibroids and weight on entry to the study. Risk increased steadily with increasing weight, so that women weighing 70 kg or more at entry had an almost threefold increased risk compared with women weighing less than 50 kg. The results were very similar when we considered Quetelet's index (weight in kg divided by height in mi2) rather than weight (table V) . The data on hospital treatments showed that infections of the urinary tract were not associated with risk of fibroids (29 in the fibroid group and 31 in the control group); that the incidence of pelvic inflammatory disease was very low in this population (five cases and two controls); and that there was a slight (not significant) excess of cases with cervicitis (71 cases and 54 controls). The association between urinary tract infections and fibroids was further weakened after excluding six women with fibroids (O controls) in whom cervicitis was diagnosed within one year of the diagnosis of fibroids. When the factors (term births, age at last term birth, menopausal state, use of oral contraceptives, weight, and cigarette smoking) that were significant when considered as univariate variables were considered jointly all remained significant and, except for the obvious relation between number of term pregnancies and age at last term pregnancy, their effects were almost independent (table VII). There was no added effect of nulliparity per se over and above that of its effect described as a linear term with number of term pregnancies.
Discussion
The strong negative association between number of term pregnancies and the occurrence of fibroids is most likely to be due to the effects of two factors. Firstly, women who develop fibroids are relatively infertile compared with women who do not, and, secondly, term pregnancies per se reduce risk.
Relative infertility seems unlikely to be the total explanation. Among our subjects absolute infertility was uncommon-89% (478) of the women with fibroids had had at least one term pregnancy (possibly partly because all the women in the study were attending family planning clinics for contraceptive advice at recruitment). Furthermore, the total use of contraceptives after entry to the study of the women with fibroids was only slightly (and not significantly) less than the total used by the control group (average duration of contraceptive use of the women with fibroids was 69 4 months compared with 71 3 months for the control group). The interval from marriage to first birth also differed very little between the fibroid and control groups (relative risk of 1 20 for 10 or more years compared with less than two years).
Finally, the hypothesis that term pregnancies actually reduce risk is also supported by the finding that risk of fibroids is further reduced with each additional term pregnancy. The protective effect of term pregnancies is, however, not the complete explanation either. There is evidence that the presence of fibroids may prevent implantation or maintenance of the ovum in the uterus in a few women: 14 women with fibroids (v five controls) reported an infertility problem during follow up, and the pregnancies occurring in the women with fibroids ended in abortion considerably more often than the pregnancies occurring in the control women. This was true even for pregnancies occurring before entry to the study.
Moreover, six of the 22 nulliparous women with fibroids achieved a term pregnancy after surgery for their fibroids.
The decrease in the risk offibroids with increasing age at last term pregnancy (even after allowing for number of term births) suggests that a term birth indicates that the woman did not have a clinically important fibroid at that time. This complements the notion that fibroids can cause infertility.
This study provides the first real evidence that the risk of fibroids is reduced by use of oral contraceptives. There is roughly a 17% reduction in risk with each five years of oral contraceptive use.
We thought a priori that use of intrauterine devices might increase risk of fibroids, particularly since heavy menstrual flow is a common side effect of the use of intrauterine devices, and this symptom might lead to increased detection of fibroids. There was, however, no evidence of an association with use of intrauterine devices.
Risk of fibroids increased with increasing body weight: risk increased roughly 21% for each 10 kg increase. Cigarette smoking was associated with a significant decrease in risk of fibroids. We estimate that women who smoked 10 cigarettes a day had an 18% decreased risk in comparison with non-smokers. These factors modifying the risk offibroids-protective effects of term births, use of oral contraceptives, cigarette smoking, and a harmful effect of increased body weight-are also the major factors associated with the risk of endometrial cancer. "Unopposed" oestrogen-that is, oestrogen exposure unaccompanied by a progestogen-has been clearly identified as the major cause ofcancer of the endometrium, and all these risk factors can be interpreted in terms of the hypothesis of unopposed oestrogen."'2 This strongly suggests that unopposed oestrogen is also the underlying cause of fibroids.
After the menopause increased weight is associated with increased concentrations of circulating oestrogen, presumably because the major source of postmenopausal oestrogens is conversion of androstenedione to oestrogen in fat cells.'3 Before the menopause this oestrogen source is fairly unimportant in the face of ovarian production, but increasing weight is still closely associated with decreasing concentrations of sex hormone binding globulin and thus presumably with increasing concentrations of bioavailable oestradiol. Cigarette smoking has also been found to be associated with lower concentrations of urinary oestrogens.'4 If infertility is associated with a high risk offibroids an oestrogen mechanism could also be proposed; this association could be due to high concentrations of unopposed oestrogen related to a high frequency of anovulatory cycles in such women. According to this hypothesis, the decreased. risk associated with term pregnancies and use of oral contraceptives would be explained most readily by the oestrogen modifying effect of progestogens.
The data on the possibly increasing protective effect -with increasing progestogen dose of oral contraceptives with the same ethinyloestradiol content (table IV) also provide some support for the unopposed oestrogen (protective effect of progestogens) hypothesis. The data on oral contraceptives containing ethynodiol diacetate are puzzling and need confirmation. Direct studies of the effect of different brands on the myometria may be informative.
Blood or urine concentrations of oestrogens in women with or without uterine. fibroids appear not to have been measured. Alterations in oestrogen concentration and in oestrogen metabolism in leiomyomatous versus normal myometrium have been reported by some,'5 but not all investigators. 16 Further work may help explain why, unlike endometrial cancer, we have been unable to find any data linking oestrogen replacement therapy in postmenopausal women to an increased risk of fibroids; this apparently anomalous observation needs to be investigated closely. It would also-be useful if future studies on women with endometrial cancer could report on the prevalence of fibroids in such women. We would, of course, expect women with endometrial cancer to have a raised risk of fibroids but we know of no data that address this issue.
